Citeline Pharmaprojects Drug Pipeline License

The U.S. Food and Drug Administration (FDA or Agency) hereby issues a notice of intent in accordance with FAR 5.201. Pursuant to FAR 13.106-1(b), the FDA will sole source with Informa Business Intelligence, Inc. (Informa), 101 Paramount Dr., Suite 100; Sarasota, FL; 34232-6044, USA for a site license for Citeline Pharmaprojects Drug Pipeline software. Informa is the only Vendor capable in meeting the requirement of this procurement.

The FDA intends to award a purchase order to Informa for twelve (12) months for the Citeline license with unlimited search access to Pharmaprojects drug pipeline database. This database provides access to over 60,000 highly detailed and fully searchable drug profiles, 13,000 of these are in active development, early stage, all the way through going to market. They are updated on a real time basis with granular information on development history timelines, licensing information, and molecular structure.

This notice is not a request for competitive quotes or proposal. No solicitation document is available and telephone requests will not be accepted. Respondents may submit information pertaining to their capabilities to provide the equivalent product required above prior to seven (7) days after the post of this notice manner to Daniel Rich, Contract Specialist, at Daniel.Rich1@ fda.hhs.gov, which may be considered by the Agency.

A determination to compete this procurement from the responses received shall be based upon the discretion of the Government. It is anticipated that an award will be issued to Informa Business Intelligence, Inc. approximately seven (7) days after the date of this notice, unless the Government determines another vendor has the capabilities of meeting this requirement and is more advantageous to the Government. All responses to this notice of intent shall be received no later than 9:00 AM Eastern Time (ET) on September 20, 2016 via email to Daniel Rich at Daniel.Rich1@ fda.hhs.gov.